# Crucumin Effects on the Immune System in Osteoarthritis Patients

> **NCT03715140** · PHASE3 · UNKNOWN · sponsor: **Mashhad University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Crucumin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03715140
- **Lead sponsor:** Mashhad University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2020-09-21
- **Final completion:** 2020-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03715140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03715140, "Crucumin Effects on the Immune System in Osteoarthritis Patients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03715140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*